Literature DB >> 22235973

Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling.

I M Hons1, M A Storr, K Mackie, B Lutz, Q J Pittman, G M Mawe, K A Sharkey.   

Abstract

BACKGROUND: The enteric nervous system (ENS) possesses extensive synaptic connections which integrate information and provide appropriate outputs to coordinate the activity of the gastrointestinal tract. The regulation of enteric synapses is not well understood. Cannabinoid (CB)(1) receptors inhibit the release of acetylcholine (ACh) in the ENS, but their role in the synapse is not understood. We tested the hypothesis that enteric CB(1) receptors provide inhibitory control of excitatory neurotransmission in the ENS.
METHODS: Intracellular microelectrode recordings were obtained from mouse myenteric plexus neurons. Interganglionic fibers were stimulated with a concentric stimulating electrode to elicit synaptic events on to the recorded neuron. Differences between spontaneous and evoked fast synaptic transmission was examined within preparations from CB(1) deficient mice (CB(1)(-/-)) and wild-type (WT) littermate controls. KEY
RESULTS: Cannabinoid receptors were colocalized on terminals expressing the vesicular ACh transporter and the synaptic protein synaptotagmin. A greater proportion of CB(1)(-/-) neurons received spontaneous fast excitatory postsynaptic potentials than neurons from WT preparations. The CB(1) agonist WIN55,212 depressed WT synapses without any effect on CB(1)(-/-) synapses. Synaptic activity in response to depolarization was markedly enhanced at CB(1)(-/-) synapses and after treatment with a CB(1) antagonist in WT preparations. Activity-dependent liberation of a retrograde purine messenger was demonstrated to facilitate synaptic transmission in CB(1)(-/-) mice. CONCLUSIONS & INFERENCES: Cannabinoid receptors inhibit transmitter release at enteric synapses and depress synaptic strength basally and in an activity-dependent manner. These actions help explain accelerated intestinal transit observed in the absence of CB(1) receptors.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235973      PMCID: PMC3276688          DOI: 10.1111/j.1365-2982.2011.01860.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  47 in total

Review 1.  Slow excitatory metabotropic signal transmission in the enteric nervous system.

Authors:  J D Wood; A Kirchgessner
Journal:  Neurogastroenterol Motil       Date:  2004-04       Impact factor: 3.598

Review 2.  Pharmacology and function of nicotinic acetylcholine and P2X receptors in the enteric nervous system.

Authors:  J J Galligan; R A North
Journal:  Neurogastroenterol Motil       Date:  2004-04       Impact factor: 3.598

3.  Mapping 5-HT inputs to enteric neurons of the guinea-pig small intestine.

Authors:  K B Neal; J C Bornstein
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

4.  Targets of myenteric interneurons in the guinea-pig small intestine.

Authors:  K B Neal; J C Bornstein
Journal:  Neurogastroenterol Motil       Date:  2007-12-11       Impact factor: 3.598

Review 5.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 6.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

7.  Alterations to enteric neural signaling underlie secretory abnormalities of the ileum in experimental colitis in the guinea pig.

Authors:  Ian M Hons; Joshua E Burda; John R Grider; Gary M Mawe; Keith A Sharkey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-12       Impact factor: 4.052

8.  A molecular basis of analgesic tolerance to cannabinoids.

Authors:  Anke Tappe-Theodor; Nitin Agarwal; István Katona; Tiziana Rubino; Lene Martini; Jakub Swiercz; Ken Mackie; Hannah Monyer; Daniela Parolaro; Jennifer Whistler; Thomas Kuner; Rohini Kuner
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

9.  Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum.

Authors:  S Baldassano; M G Zizzo; R Serio; F Mulè
Journal:  Br J Pharmacol       Date:  2009-05-20       Impact factor: 8.739

10.  Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.

Authors:  Maria Antonietta Casu; Anna Porcella; Stefania Ruiu; Pierluigi Saba; Giorgio Marchese; Mauro Antonio Maria Carai; Roberta Reali; Gian Luigi Gessa; Luca Pani
Journal:  Eur J Pharmacol       Date:  2003-01-10       Impact factor: 4.432

View more
  11 in total

1.  Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.

Authors:  M Bashashati; Y Nasser; C M Keenan; W Ho; F Piscitelli; M Nalli; K Mackie; M A Storr; V Di Marzo; K A Sharkey
Journal:  Br J Pharmacol       Date:  2015-04-23       Impact factor: 8.739

2.  AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

Authors:  C M Keenan; M A Storr; G A Thakur; J T Wood; J Wager-Miller; A Straiker; M R Eno; S P Nikas; M Bashashati; H Hu; K Mackie; A Makriyannis; K A Sharkey
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 3.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

Review 4.  The roles of purinergic signaling during gastrointestinal inflammation.

Authors:  Jane A Roberts; Mark K Lukewich; Keith A Sharkey; John B Furness; Gary M Mawe; Alan E Lomax
Journal:  Curr Opin Pharmacol       Date:  2012-10-11       Impact factor: 5.547

Review 5.  Intestinal lipid-derived signals that sense dietary fat.

Authors:  Nicholas V DiPatrizio; Daniele Piomelli
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

6.  Role of corticosterone in the murine enteric nervous system during fasting.

Authors:  Katrien Lowette; Jan Tack; Pieter Vanden Berghe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

Review 7.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

Review 8.  Endocannabinoid signaling at the periphery: 50 years after THC.

Authors:  Mauro Maccarrone; Itai Bab; Tamás Bíró; Guy A Cabral; Sudhansu K Dey; Vincenzo Di Marzo; Justin C Konje; George Kunos; Raphael Mechoulam; Pal Pacher; Keith A Sharkey; Andreas Zimmer
Journal:  Trends Pharmacol Sci       Date:  2015-03-18       Impact factor: 14.819

9.  Endocannabinoids in the Gut.

Authors:  Nicholas V DiPatrizio
Journal:  Cannabis Cannabinoid Res       Date:  2016-02-24

10.  Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.

Authors:  Arthur Lionnet; Matthew A Wade; Anne-Gaëlle Corbillé; Alice Prigent; Sébastien Paillusson; Maddalena Tasselli; Jacques Gonzales; Emilie Durieu; Malvyne Rolli-Derkinderen; Emmanuel Coron; Emilie Duchalais; Michel Neunlist; Michael S Perkinton; Diane P Hanger; Wendy Noble; Pascal Derkinderen
Journal:  Acta Neuropathol Commun       Date:  2018-07-23       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.